Gaynor R, Herschman H R, Irie R, Jones P, Morton D, Cochran A
Lancet. 1981 Apr 18;1(8225):869-71. doi: 10.1016/s0140-6736(81)92142-5.
S100 protein is a nervous-system-specific cytoplasmic protein which is also present in human malignant melanoma cell lines. To test for its tumour specificity, biopsy specimens from normal tissue and a wide variety of tumours were tested for S100 by complement fixation and immunofluorescence tests. S100 was present in all of thirteen samples of malignant melanoma tissue and absent from nineteen samples of non-melanocytic tumours, and from normal skin and normal lymph nodes. S100 levels did not correlate with tyrosinase activity in the tissues examined. Detection and measurement of S100 protein may help distinguish poorly differentiated amelanotic malignant melanoma from tumours of obscure histological origin; they may also aid the detection of micrometastatic disease in the lymph nodes and other tissues of melanoma patients.
S100蛋白是一种神经系统特异性细胞质蛋白,也存在于人类恶性黑色素瘤细胞系中。为检测其肿瘤特异性,通过补体结合试验和免疫荧光试验对来自正常组织和多种肿瘤的活检标本进行了S100检测。在13份恶性黑色素瘤组织样本中均检测到S100,而在19份非黑素细胞肿瘤样本、正常皮肤和正常淋巴结中未检测到。在所检测的组织中,S100水平与酪氨酸酶活性无关。S100蛋白的检测和测量可能有助于将低分化无色素性恶性黑色素瘤与组织学来源不明的肿瘤区分开来;它们还可能有助于检测黑色素瘤患者淋巴结及其他组织中的微转移疾病。